Open AccessRibociclib and everolimus in well-differentiated foregut neuroendocrine tumors
Author(s) -
Nitya Raj,
Youyun Zheng,
Haley Hauser,
Joanne F. Chou,
Johnathan Rafailov,
Jad Bou-Ayache,
Peter Sawan,
Jamie E. Chaft,
Jennifer A. Chan,
Kimberly Perez,
Charles M. Rudin,
Laura Tang,
Diane ReidyLagunes
Publication year - 2021
Publication title -
endocrine related cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.892
H-Index - 130
eISSN - 1479-6821
pISSN - 1351-0088
DOI - 10.1530/erc-20-0446
Subject(s) - everolimus , medicine , foregut , neuroendocrine tumors , clinical endpoint , oncology , progressive disease , phases of clinical research , progression free survival , biomarker , clinical trial , surgery , gastroenterology , disease , chemotherapy , biology , biochemistry , anatomy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom